Use of health outcome and health service utilization indicators as an outcome of access to medicines in Brazil: perspectives from a literature review

Abstract

BackgroundTo guarantee the right to health, the health system must also ensure access to medicines. Several financial arrangements to provide these technologies are implemented and range from the direct (either total or partial) to indirect payment by the patient, being necessary to evaluate its effect on access to medicines. However, to ensure access to medicines is not just about ensuring its availability, as this only materializes in its use. Thus, evaluation studies of interventions in access to medicines have been using indicators related to the health results and use of health services as its outcomes. Furthermore, as this relationship is not direct, it is important to critically assess the adequacy of these tools to measure this phenomenon and, additionally, the ability to use it in the Brazilian scenario. Therefore, this study sought to identify, describe, and analyze the use of these indicators as medicine access outcomes, through a review of the scientific literature.MethodsAn extensive literature review was done using a bibliographic database for a systematic review. The references were selected based on inclusion and exclusion criteria, and the indicators from the papers retained were analyzed using the parameters of validity, measurability, reliability, and relevance.ResultsWe have analyzed over 12,000 references of which 30 references were included, describing the use of 49 health outcomes and health service use indicators. The majority reported the use of health service utilization measures. In our evaluation, the best indicators for assessing the effects of co-payment intervention on access are the ones aimed at specific populations or symptomatic health conditions in which the response to the therapeutic treatment is known and occurs in a short period of time. It was evident the lack of information on the indicators analyzed as well as the limitation of the Brazilian secondary databases for its calculation.ConclusionsThis research showed the variety and heterogeneity of the indicators used in scientific studies. The best indicators for access to medicines are sought to measure the use of health services for symptomatic health conditions that are quickly responsive to pharmacological treatment, while the indicators related to worker productivity loss was the most suitable for health outcomes.Electronic supplementary materialThe online version of this article (10.1186/s40985-019-0115-1) contains supplementary material, which is available to authorized users.

Ethnic Inequalities in Healthcare Use and Care Quality among People with Multiple Long-Term Health Conditions Living in the United Kingdom: A Systematic Review and Narrative Synthesis

“…Healthcare use can be defined as the quantification or description of the use of services by persons for the purpose of preventing and curing health problems, promoting maintenance of health and well-being, or obtaining information about one’s health status and prognosis [ 41 ]. Indicators of healthcare use include GP consultations, hospital visits including inpatient, outpatient and day visits, hospital admissions, accidents and emergency department visits, diagnoses, prescriptions, referrals, immunisations and screening [ 29 , 42 , 43 ]. In contrast, healthcare quality has been defined as the degree to which healthcare services increase the chances of desired health outcomes for people and are aligned with current professional knowledge [ 44 ].…”

The impact of long-term care interventions on healthcare utilisation among older persons: a scoping review of reviews

“…The search was limited to the year 2010 onwards to allow for the identification of recent evidence. As the aim of this study was to support health systems planning, only healthcare service utilisation reported from a health systems perspective was included, such as a) Hospital utilisation, b) Emergency department (ED) utilisation, c) Medication utilisation, and d) Primary care utilisation [ 26 ].…”

Assessment of the performance of the Brazilian Portuguese Nottingham Health Profile in adult growth hormone deficiency and pulmonary hypertension

“…As a result of the lack of responsiveness and age of the generic measures, they are being replaced by disease-specific PROMs. However, in medium and low-income countries, there is a lack of comprehensive information systems, creating methodological obstacles in evaluation studies and limiting the capacity to conduct longitudinal studies 3 . Healthcare professionals, researchers and pharmaceutical companies are therefore reliant on generic outcome measures to collect information from patients because, theoretically, they can be used with any patient population.…”